间充质干细胞经巨噬细胞重编程修复骨髓微环境抑制白血病
该研究利用白血病模型和RNA-Seq分析,发现白血病进展中骨髓间充质干细胞(MSC)功能退化。骨髓腔内而非全身输注健康供者MSC可恢复宿主MSC功能、改善血小板生成并重建髓系平衡,从而减轻肿瘤负荷并延长荷瘤小鼠生存。机制上,供者MSC将宿主巨噬细胞重编程为Arg1阳性修复表型,输注这些巨噬细胞可重现MSC的治疗效应。
要点
- 白血病进展导致骨髓MSC功能退化。
- 骨髓腔内输注健康MSC可修复微环境并抑制白血病。
- MSC通过重编程宿主巨噬细胞为Arg1阳性表型发挥治疗作用。
核心结论
- 供者MSC通过重编程宿主巨噬细胞恢复骨髓微环境并抑制白血病发展。
研究设计与样本
- 研究采用已建立的白血病模型并结合RNA-Seq分析,评估MSC功能及治疗效应。
主要发现
- 白血病进展过程中MSC发生功能退化。
- 骨髓腔内输注供者健康MSC恢复了宿主MSC功能、改善了血小板生成并重建了髓系平衡。
- 骨髓腔内MSC治疗降低了荷瘤小鼠肿瘤负荷并延长了生存。
- 供者MSC将宿主巨噬细胞重编程为精氨酸酶1(Arg1)阳性且具组织修复特征的表型。
- 输注经MSC重编程的巨噬细胞在很大程度上重现了MSC的治疗效应。
临床怎么用
- 骨髓腔内局部输注健康MSC可能作为修复白血病骨髓微环境的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bone marrow (BM) mesenchymal stem cells (MSCs) are critical components of the BM microenvironment and play an essential role in supporting hematopoiesis. Dysfunction of MSCs is associated with the impaired BM microenvironment that promotes leukemia development. However, whether and how restoration of the impaired BM microenvironment can inhibit leukemia development remain unknown. Using an established leukemia model and the RNA-Seq analysis, we discovered functional degeneration of MSCs during leukemia progression. Importantly, intra-BM instead of systemic transfusion of donor healthy MSCs restored the BM microenvironment, demonstrated by functional recovery of host MSCs, improvement of thrombopoiesis, and rebalance of myelopoiesis. Consequently, intra-BM MSC treatment reduced tumor burden and prolonged survival of the leukemia-bearing mice. Mechanistically, donor MSC treatment restored the function of host MSCs and reprogrammed host macrophages into arginase 1 positive phenotype with tissue-repair features. Transfusion of MSC-reprogrammed macrophages largely recapitulated the therapeutic effects of MSCs. Taken together, our study reveals that donor MSCs reprogram host macrophages to restore the BM microenvironment and inhibit leukemia development.
引用
- Xia C, Wang T, Cheng H, et al. Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironment. Leukemia. 2020. PMID: 32094463. doi:10.1038/s41375-020-0775-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。